| Financial Year |
March 31 2023 |
| Monetary Funds |
798,514,896.20 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
23,209,230.44 |
| Accounts Receivable |
207,122,161.71 |
| Advances to Suppliers |
13,184,577.84 |
| Other Receivables |
14,050,150.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
228,759,835.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
39,121,980.99 |
| Total Current Assets |
1,359,816,819.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
10,970,396.46 |
| Long-term Equity Investment |
-- |
| Investment Properties |
25,024,144.98 |
| Fixed Assetes |
351,430,761.09 |
| Under-construction Projects |
40,573,081.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
66,561,076.11 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
21,587,018.67 |
| Other Non-Current Assets |
2,207,450.80 |
| Sub-Total of Non-Current Assets |
677,800,915.24 |
| Total Assets |
2,037,617,734.78 |
| Short-Term Loans |
60,087,694.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
120,783,945.00 |
| Accounts Payable |
272,754,488.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,147,358.58 |
| Taxes Payable |
12,607,956.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
100,357,415.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
51,049,206.04 |
| Sub-Total of Current Liabilities |
860,870,100.47 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,980,506.78 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
20,742,092.93 |
| Total Liabilities |
881,612,193.40 |
| Paid-In Capital(Or Share Stock) |
307,000,000.00 |
| Capital Surplus |
344,863,254.73 |
| Surplus Reserve |
50,380,159.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
407,103,969.18 |
| Minority Stockholder's Interest |
2,885,029.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,153,120,512.30 |
| Owner's Equity（Stockholder's Equity） |
1,156,005,541.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,037,617,734.78 |
